Stockholm - Delayed Quote SEK

SciBase Holding AB (publ) (SCIB.ST)

0.4250
+0.0350
+(8.97%)
At close: 3:42:00 PM GMT+2
Loading Chart for SCIB.ST
  • Previous Close 0.3900
  • Open 0.4100
  • Bid 0.4010 x --
  • Ask 0.4270 x --
  • Day's Range 0.3850 - 0.4250
  • 52 Week Range 0.2530 - 0.6000
  • Volume 145,514
  • Avg. Volume 194,726
  • Market Cap (intraday) 143.776M
  • Beta (5Y Monthly) 1.23
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3400
  • Earnings Date Aug 19, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 1.40

SciBase Holding AB (publ), a medical technology company, develops and sells point-of-care platforms that utilizes electrical impedance spectroscopy for the evaluation of skin disorders in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and assess skin barrier and inflammation. It has a collaboration with Vrije Universiteit Brussel University hospitals for early detection of atopic diseases in infants through the use of electrical impedance spectroscopy technology. SciBase Holding AB (publ) was founded in 1998 and is headquartered in Sundbyberg, Sweden

scibase.com

32

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SCIB.ST

View More

Performance Overview: SCIB.ST

Trailing total returns as of 5/19/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

SCIB.ST
3.66%
OMX Stockholm 30 Index (^OMX)
2.65%

1-Year Return

SCIB.ST
55.11%
OMX Stockholm 30 Index (^OMX)
2.05%

3-Year Return

SCIB.ST
90.13%
OMX Stockholm 30 Index (^OMX)
27.93%

5-Year Return

SCIB.ST
80.63%
OMX Stockholm 30 Index (^OMX)
63.36%

Compare To: SCIB.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SCIB.ST

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    131.94M

  • Enterprise Value

    104.61M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.34

  • Price/Book (mrq)

    3.60

  • Enterprise Value/Revenue

    3.52

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -205.77%

  • Return on Assets (ttm)

    -66.61%

  • Return on Equity (ttm)

    -153.38%

  • Revenue (ttm)

    29.7M

  • Net Income Avi to Common (ttm)

    -61.12M

  • Diluted EPS (ttm)

    -0.3400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    11.24M

  • Total Debt/Equity (mrq)

    43.81%

  • Levered Free Cash Flow (ttm)

    -68.06M

Research Analysis: SCIB.ST

View More

Company Insights: SCIB.ST

Research Reports: SCIB.ST

View More

People Also Watch